Costs of Lower-Extremity Ulcers Among Patients With Diabetes
The DOI matches its Crossref record.
Abstract
OBJECTIVE—The objective of this study was to characterize health care costs associated with diabetic lower-extremity ulcers. RESEARCH DESIGN AND METHODS—Adult patients with diabetes who had a lower-extremity ulcer episode during 2000 and 2001 were identified using claims data. Ulcer-related direct health care costs were computed for each episode. Episodes were stratified according to severity level based on the Wagner classification. RESULTS—A total of 2,253 patients were identified. The mean age was 68.9 years, and 59% of the patients were male. The average episode duration was 87.3 ± 82.8 days. Total ulcer-related costs averaged $13,179 per episode and increased with severity level, ranging from $1,892 (level 1) to $27,721 (level 4/5). Inpatient hospital charges accounted for 77% ($10,188) of the overall cost, indicating that hospitalization was a major cost driver. Total ulcer-related costs were significantly higher for patients <65 years of age compared with those of older patients ($16,390 vs. $11,925, P = 0.02) and for patients with inadequate vascular status compared with patients with adequate vascular status ($23,372 vs. $5,218, P < 0.0001). Patients who progressed to a higher severity level also had significantly higher ulcer-related costs compared with patients who did not progress ($20,136 vs. $3,063, P < 0.0001). CONCLUSIONS—The high costs of treating diabetic lower-extremity ulcers emphasize the value of intensive outpatient interventions designed to prevent ulcer progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Global Vascular Guidelines on the management of chronic limb-threatening ischemia.
Conte, M. S., Bradbury, A. W., Kolh, P., White, J. V., Dick, F., Fitridge, R., Mills, J. L., Ricco, J.-B., Suresh, K. R., Murad, M. H., et al. (2019) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2019.02.016 · Cited by 2,015
Global vascular guidelines on the management of chronic limb-threatening ischemia
Conte, M. S., Bradbury, A. W., Kolh, P., White, J. V., Dick, F., Fitridge, R., Mills, J. L., Ricco, J.-B., Suresh, K. R., Murad, M. H., et al. (2019) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2019.05.006 · Cited by 1,582
Burden of Diabetic Foot Ulcers for Medicare and Private Insurers
Rice, J. B., Desai, U., Cummings, A. K. G., Birnbaum, H. G., Skornicki, M., & Parsons, N. B. (2014) · Diabetes Care · doi:10.2337/dc13-2176 · Cited by 624
“Other existing literature on the burden of DFUs in the US calculated the overall healthcare costs (as opposed to incremental) without reference to a non-DFU control population (9-11).”
BackgroundThe costs of diabetic foot: The economic case for the limb salvage team
Driver, V. R., Fabbi, M., Lavery, L. A., & Gibbons, G. (2010) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2010.06.003 · Cited by 505
Prompers, L., Huijberts, M., Schaper, N., Apelqvist, J., Bakker, K., Edmonds, M., Holstein, P., Jude, E., Jirkovska, A., Mauricio, D., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1089-6 · Cited by 306
Classification of foot ulcers in people with diabetes: a systematic review.
Monteiro‐Soares, M., Hamilton, E. J., Russell, D. A., Srisawasdi, G., Boyko, E. J., Mills, J. L., Jeffcoate, W., & Game, F. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3645 · Cited by 59
“Two studies, one at high and one at low risk of bias, reported an increase in costs of treatment over 1 year with each increase in Wagner grade, 120,121 domains with increasing Wagner grade.”
BackgroundEren, M. A., Güneş, A. E., Kırhan, İ., & Sabuncu, T. (2020) · Acta Orthopaedica et Traumatologica Turcica · doi:10.5152/j.aott.2020.02.518 · Cited by 22
Metadata
- Authors
- Stockl, K., Vanderplas, A., Tafesse, E., & Chang, E.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2004-09-01
- Volume
- 27
- Issue
- 9
- Pages
- 2129-2134
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2138207544
- Cited by
- 198
- References
- 0
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.